Susquehanna International Group, LLP Boston Scientific Corp Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 450,941 shares of BSX stock, worth $41.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

450,941

Previous 384,888 17.16%

Holding current value

$41.2 Million

Previous $29.6 Million 27.49%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $4.82 Million - $5.55 Million	66,053 Added 17.16%	450,941 $37.8 Million
Q2 2024 Aug 15, 2024	BUY	$67.33 - $77.71 $294,299 - $339,670	4,371 Added 1.15%	384,888 $29.6 Million
Q1 2024 May 07, 2024	SELL	$57.6 - $68.62 $19.6 Million - $23.4 Million	-340,829 Reduced 47.25%	380,517 $26.1 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $16 Million - $19 Million	-329,400 Reduced 31.35%	721,346 $41.7 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $7.72 Million - $8.42 Million	153,903 Added 17.16%	1,050,746 $55.5 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $30.4 Million - $33.4 Million	-610,838 Reduced 40.52%	896,843 $48.5 Million
Q1 2023 May 16, 2023	BUY	$45.09 - $50.03 $42.2 Million - $46.8 Million	935,727 Added 163.6%	1,507,681 $75.4 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $20.1 Million - $24 Million	508,728 Added 804.62%	571,954 $26.5 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $5.41 Million - $16.1 Million	-147,271 Reduced 69.96%	63,226 $2.45 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $7.29 Million - $9.75 Million	-206,921 Reduced 49.57%	210,497 $7.85 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $2.13 Million - $2.35 Million	-52,185 Reduced 11.11%	417,418 $18.5 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $6.74 Million - $7.94 Million	176,927 Added 60.45%	469,603 $19.9 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $29.6 Million - $32.9 Million	-717,871 Reduced 71.04%	292,676 $12.7 Million
Q2 2021 Aug 11, 2021	BUY	$38.58 - $44.24 $20.3 Million - $23.3 Million	525,637 Added 108.4%	1,010,547 $43.2 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $15.1 Million - $16.9 Million	-427,258 Reduced 46.84%	484,910 $18.7 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $21.5 Million - $27.2 Million	648,470 Added 245.91%	912,168 $32.8 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $33.8 Million - $41.4 Million	-980,668 Reduced 78.81%	263,698 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $10.2 Million - $13.3 Million	339,150 Added 37.47%	1,244,366 $43.7 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $14.5 Million - $25.7 Million	562,132 Added 163.85%	905,216 $29.5 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $7.71 Million - $9.24 Million	203,560 Added 145.9%	343,084 $15.5 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $33.2 Million - $35.8 Million	-824,805 Reduced 85.53%	139,524 $5.68 Million
Q2 2019 Aug 16, 2019	BUY	$34.91 - $42.98 $2.74 Million - $3.38 Million	78,621 Added 8.88%	964,329 $41.4 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $30.6 Million - $37.7 Million	876,400 Added 9415.56%	885,708 $38.1 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $327,448 - $418,704	-12,200 Reduced 56.72%	9,308 $304,000
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $10.8 Million - $12.2 Million	-428,063 Reduced 95.22%	21,508 $588,000
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $10.6 Million - $12.7 Million	427,105 Added 1901.12%	449,571 $11.1 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $589,957 - $655,333	22,466	22,466 $655,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $131B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Boston Scientific Corp Transaction History